Navigation Links
Infrared Systems International Reflects on Past and Looks Forward to the Future

SILVERDALE, Wash., Aug. 26, 2011 /PRNewswire/ -- Infrared Systems International (OTCBB: IFRS) announces the completion of several internal projects and discusses corporate strategies for continued success.

Most recently, the company completed the pre-planned distribution of the assets of its subsidiary, Infrared Applications, Inc. (IAI).  The distribution marks the next phase in the transition of the company from one engaged in the aerospace industry to one focused on biotechnology and life sciences.  In the process of the distribution, the company was also able to strengthen its balance sheet by shedding over $85,000 in current liabilities.

"We are focused on making decisions that will benefit the company in the long run," stated Bill Wright, CEO of Infrared Systems International. "The distribution of Infrared Applications, Inc., our past, and the strategic acquisition of AquaLiv, Inc., our future, are milestones in what promises to be a long and exciting journey."

"Aqualiv's technology represents the future of several industries and will be incredibly disruptive in the marketplace," added Mr. Wright. "Our short term goals include creating a more recognizable identity in the market, supporting AquaLiv's clinical trials through completion, and winning approval to market NatuRx(TM) HIV/AIDS in Kenya."

"For us, being part of Infrared Systems is the best of both worlds," stated AquaLiv, Inc. CEO, Craig Hoffman. "We remain partially private and protect the technology from takeover, but at the same time provide an opportunity for the public to participate in something we believe is going to be a revolution in science and industry."

Earlier this year, the AquaLiv released its first agriculture product, AgSmart(TM) Rice. The product increases yields in rice crops an average of 30% and is compatible with all existing agriculture technologies, including organic growing standards. The company also introduced a drug-free HIV/AIDS treatment that is beginning clinical trials in Kenya. The treatment outperforms existing antiretroviral drugs and does so without their harsh side effects. All NatuRx(TM) treatments can be manufactured at a significantly lower cost than traditional drugs.

For more information about AquaLiv, visit their website:

About Infrared Systems International:

Infrared Systems International, through its subsidiaries, offers unique solutions and applications for a variety of industries and emerging technologies.

AquaLiv, Inc. is a life sciences research and development company creating novel products for numerous industries. The company's patented technology alters the behavior of organisms, including plants and humans, without chemical interaction. From increased crop yields to drug-free medicine, AquaLiv is providing innovative, ingredient-free solutions to the world's largest problems. To learn more about AquaLiv, please visit:

Focus Systems, Inc. is a service orientated, desktop virtualization, and VoIP information technology provider. Focus Systems' service essentially eliminates the need for their customers to buy, deploy, and maintain IT infrastructure. The move to cloud computing lowers customers' total cost of ownership by shifting critical systems to Focus -- including servers, backup, software, operating systems, updates, power, cooling, facility space, and internal staffing requirements. For more information, please visit:

Safe Harbor: Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.

Infrared Systems International

SOURCE Infrared Systems International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. LI-COR Adds Four New IRDye(R) Infrared Dye Antibodies to its Product Line
2. LI-COR Introduces Three IRDye(R) Near-Infrared Fluorescence Resonance Energy Transfer (NIR-FRET) Protease Substrates
3. Technical Note: E-PAGE(TM) 48- and 96-Well Gels on the Odyssey(R) Infrared Imaging System
4. First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter
5. Nanotech discovery at Rensselaer could lead to breakthrough in infrared satellite imaging technology
6. Transmission lines for nanofocusing of infrared light
7. Infrared Systems Internationals Subsidiary, AquaLiv, Inc., Strives to Be a Game Changer in Fight Against HIV/AIDS
8. Infrared Systems Internationals Subsidiary, AquaLiv Inc., Explains Its Revolutionary Technology in Laymans Terms
9. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
10. North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes
11. Avantis Medical Systems, Inc. Announces Key Leadership Appointments
Post Your Comments:
(Date:11/28/2015)... ... ... • Jeon Jin Bio Corp, a Korean Biotech venture company, has developed ... Bird Free, an oil-based, gel formula made from natural ... smell, taste and touch, enabling safe, effective avian control without toxic chemicals , ...
(Date:11/26/2015)... 26, 2015 --> ... in imaging technologies, announced today that it has received a ... the Horizon 2020 European Union Framework Programme for Research and ... trial in breast cancer. , --> ... --> --> The study aims to ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 /PRNewswire/ ... ), a biotechnology company developing bioengineered organ implants for ... will present at the LD Micro "Main Event" ... p.m. PT. The presentation will be webcast live and ... will also be available at the conference for one-on-one ...
(Date:11/25/2015)... November 25, 2015 The ... is a professional and in-depth study on the ...      (Logo: ) , ... industry including definitions, classifications, applications and industry chain ... the international markets including development trends, competitive landscape ...
Breaking Biology Technology:
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
Breaking Biology News(10 mins):